$7.73-0.90%
2026-10-09 close · prelimLoading chart…
Evolus's chart data is dated 2026-10-09. There is no active technical signal. There are 10 published signal records.
Evolus last closed at $7.73 (-0.90%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -15.0×. Its overall grade ranks 5 of 738 stocks in Healthcare.
About this company
Evolus last closed at $7.73 (-0.90%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 5/738
Valuation grade A+
Related stocks
- AbbVieCompetitor
미용/보툴리눔 톡신 시장에서 Jeuveau와 경쟁하는 주요 업체
- GaldermaCompetitor
미용 톡신·에스테틱 제품군에서 경쟁하는 글로벌 업체
- IpsenCompetitor
보툴리눔 톡신 및 에스테틱 분야의 경쟁사
About Evolus
- What technical signals does Evolus (EOLS) have?
- Evolus current technical signals: no active technical signal.
- Is Evolus a cup-and-handle pattern?
- No. Evolus has no valid Cup signal right now.
- What published figures are available for Evolus?
- Market cap: $501.06M. Trailing 12 months PER: -15.0×. Latest quarter PBR: -16.64×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Evolus, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy